INOVATIONS IN
Detection, Treatment and Management

Big strides in improving the outcome of cancer care depend heavily on new therapies and recent innovations. Building on the success of NFCC 2024, we intend to repeat the meeting in

2025. This time, the weekend meeting will be held over two days in Dubai, providing attendees with straightforward and practical knowledge.
      In our agenda, we have dedicated a session on colon cancer screening through the detection of tumor cell-free DNA, emphasizing the critical role of early detection in improving outcomes.
      Additionally, we will cover the emerging role of cell therapy in oncology, ensuring hematologists and oncologists gain familiarity with this modality—understanding, in particular, the specific
      diseases it targets and the optimal stages of cancer care for its application.
      The meeting will predominantly focus on the latest therapies for solid organ tumors. Each presentation will address new advancements at different stages of cancer, and our key objectives
      include:

Highlighting local experiences and insights in utilizing these new therapies.
I hope that all attendees will have an enjoyable and fruitful meeting and benefit greatly from the opportunity to engage with speakers and peers so that they can go back and enhance
patient care. I also hope that everybody will enjoy their time in Dubai.
Thank you for your Support!

Learning the fitting of new cancer drugs within treatment algorithms.

Building confidence in prescribing the drugs effectively.

Anticipating and managing associated side effects.

Accurately assessing disease response to new treatments.

Meeting President
Aladdin Maarraoui, MD, FACP
Consultant and Chief of Hematology/Oncology

Day 2: Sunday 23rd of February 2025 – Session 4/5